InvestorsHub Logo
icon url

jmvho

09/03/22 12:36 PM

#372546 RE: falconer66a #372545

falconer66a - Many thanks for your continued, invaluable contributions to this board!

jmvho
icon url

Investor2014

09/03/22 12:48 PM

#372548 RE: falconer66a #372545

No, the dispersion index on that slide 12 says noting about cognition.

That slide is strictly only about Exposure and Dose (PK) as as statistical test on the small n=32 sample to see if it might be representative of A2-73 PK in the general AD population.
icon url

plexrec

09/03/22 8:37 PM

#372583 RE: falconer66a #372545

falconer-" are accurately predictive of subsequent Phase 3 trials"--outstanding post--much appreciate your contributions here !!!! Very long Avxl !!!!
icon url

georgejjl

09/03/22 9:45 PM

#372586 RE: falconer66a #372545

Falconer, I agree!!!

As always before, the data and results from every clinical test of blarcamesine, even Phase 1 and Phase 2 trials, are accurately predictive of subsequent Phase 3 trials. The data from the big Phase 3 Alzheimer's clinical trial are going to be exceptionally positive.



Good luck and GOD bless,